Ryzodeg, a combination of ultra-long acting and rapid-acting insulin (70% insulin degludec /30% insulin aspart, IDegAsp), has been listed on the PBS from 1 August. Indicated for use in adults with diabetes, the long duration of action beyond 24 hours for insulin degludec, means that the combination can be delivered as a once-daily injection, according to manufacturer ...
Type 1 diabetes
PBS listing for insulin degludec with insulin aspart (Ryzodeg)
3 Aug 2018